TP53 and neoplasm: We assessed tumor size and the number of tumors initiated and found that tp53-/- mutant ERMS displayed a significant increase in size (Figure 1B and D; p<0.0001) and in the number of tumors per animal (Figure 1B and C; p<0.0001) compared to tp53+/+ animals.